Clinical Diagnostics Industry Leader Scott Madel Joins Biomerica’s Team as Chief Commercial Officer

About this update from Biomerica, Inc.

[{"type":"image","alt":"Biomerica, Inc.","displaySize":"","headline":null,"caption":"Biomerica, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":232,"height":39,"url":"https://media.zenfs.com/en/globenewswire.com/af40ff522792b4c3d1be4034218ddeca"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/m66J9gaNGHXIlBdKngBmxQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTcxO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/af40ff522792b4c3d1be4034218ddeca","width":232,"height":39}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Brings 20+ years of revenue growth leadership in laboratory testing, clinical diagnostics and global expansion","length":110,"tagName":"p"}]},{"val":[{"type":"text","content":"Led successful organizational turnarounds and growth strategies at both Boston Heart Diagnostics and Genova Diagnostics","length":119,"tagName":"p"}]},{"val":[{"type":"text","content":"Extensive track record in commercializing advanced laboratory testing, driving growth and payer strategies","length":106,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":335,"olType":false},{"type":"text","content":"IRVINE, Calif., June 26, 2025 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA), a global biomedical company leading the way in innovative gastroenterology solutions, today announced the appointment of Scott Madel as Chief Commercial Officer.","length":242,"tagName":"p"},{"type":"text","content":"Scott brings more than two decades of cross-functional expertise in healthcare, diagnostics, commercialization, and payor strategy. Most recently, he served as President of Boston Heart Diagnostics, where he led a successful organizational turnaround, introduced novel cardiovascular testing technologies across diverse payer channels, and significantly boosted revenue through personalized testing solutions.","length":409,"tagName":"p"},{"type":"text","content":"Prior to Boston Heart, he served as CEO of BioHealth Diagnostics and CEO of Genova Diagnostics Europe after initially joining Genova as Vice President of Business Development. During his tenure, he helped grow Genova to over $100 million in annual revenue, launching diagnostics for chronic disease, the development of strategic partnerships across 45 countries, and the profitable turnaround and expansion of an accredited European clinical laboratory.","length":4...

More updates from Biomerica, Inc.